Institute for Wealth Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
Institute for Wealth Management's BBC Position: Q3 2026 in Review
Institute for Wealth Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026, closing a stake of 1,890 shares — an estimated $100K sold.
Institute for Wealth Management first reported a position in BBC in Q2 2026 and held it in 1 quarter. The position peaked at $100K in Q2 2026. 17 funds tracked by Wall St. Rank hold BBC as of Q3 2026.
- Institute for Wealth Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2026 after selling out during the quarter.
- Institute for Wealth Management sold 1,890 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $100K.
- Institute for Wealth Management first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2026 and held it in 1 quarter.
- Institute for Wealth Management's Virtus Biotech Clinical Trials ETF position peaked at $100K in Q2 2026.
- 17 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.
Based on Institute for Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.